Nigel Harford
About
In The Last Decade
Nigel Harford
15 papers receiving 924 citations
Hit Papers
Peers
Comparison fields: 5 of 63
- Endocrinology 463
- Molecular Biology 422
- Genetics 293
- Immunology 265
- Ecology 164
Countries citing papers authored by Nigel Harford
This map shows the geographic impact of Nigel Harford's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nigel Harford with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nigel Harford more than expected).
Fields of papers citing papers by Nigel Harford
This network shows the impact of papers produced by Nigel Harford. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nigel Harford. The network helps show where Nigel Harford may publish in the future.
Co-authorship network of co-authors of Nigel Harford
This figure shows the co-authorship network connecting the top 25 collaborators of Nigel Harford. A scholar is included among the top collaborators of Nigel Harford based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nigel Harford. Nigel Harford is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 118 | |
| 2 | 16 | |
| 3 | Development of a hepatitis B vaccine from transformed yeast cells. | 45 |
| 4 | Construction and characterization of a Saccharomyces cerevisiae strain (RIT4376) expressing hepatitis B surface antigen. | 26 |
| 5 | Construction and characterization of a saccharomyces cerevisiae strain rit 4376 expressing hepatitis b surface antigen | 4 |
| 6 | 11 | |
| 7 | Production in yeast of hepatitis B surface antigen by R-DNA technology. | 20 |
| 8 | Expression of hepatitis B surface antigen in yeast. | 43 |
| 9 | Cholera toxin genes: nucleotide sequence, deletion analysis and vaccine development breakdown → | 545 |
| 10 | 73 | |
| 11 | 34 | |
| 12 | 7 | |
| 13 | 17 | |
| 14 | 14 | |
| 15 | 83 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.